C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/30 (2006.01) A61K 31/44 (2006.01) C07D 213/16 (2006.01)
Patent
CA 2265826
This invention is concerned with a novel process for the preparation of a compound of structural formula (I) wherein R1 and R2 independently are aryl, C2-15 alkenyl or C1-15 alkyl, either unsubstituted or substituted with one or three substituents, which can be the same or different, selected from the group consisting of Ra, wherein Ra belongs to a group consisting of C1-6 alkyl, aryl, halo, -N(R3)2, -NO2, -CN, -OR3, -C3-6 cycloalkoxy, -CO(R3), - COOR3, SO2R3 and -SR3; wherein R3 is selected from the group consisting of hydrogen, C1-6 alkyl, C2-6 alkenyl and aryl, said alkyl, alkenyl or aryl optionally substituted with 1 to 3 groups of Ra, which is an important antiasthmatic agent.
Cette invention concerne un nouveau procédé de préparation d'un composé de la formule structurelle (I) dans laquelle R?1¿ et R?2¿ représentant indépendamment aryle, alcényle C¿2-15? ou alkyle C¿1-15?, soit non substitué soit substitué par un à trois substituants, lesquels peuvent être identiques ou différents, sélectionnés dans le groupe constitué de Ra, dans lequel Ra appartient à un groupe comprenant alkyle C¿1-6?, aryle, halo, -N(R?3¿)¿2?, -NO¿2?, -CN, -OR?3¿, cycloalcoxy-C¿3-6?, -CO(R?3¿), -COOR¿3?, SO¿2?R?3¿ et -SR?3¿, où R?3¿ est choisi dans le groupe constitué d'hydrogène, alkyle C¿2-6?, alcényle C¿2-6? et aryle, lesdits alkyle, alcényle ou aryle étant facultativement substitués par 1 à 3 groupes de R?a¿, le composé de l'invention étant un agent antiasthmatique important.
Dorziotis Ilias K.
Houpis Ioannis N.
Lee Jaemoon
Volante Ralph P.
Merck & Co. Inc.
Ogilvy Renault
LandOfFree
Method of preparing phosphodiesterase iv inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing phosphodiesterase iv inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing phosphodiesterase iv inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1740034